A study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a significantly lower risk of reinfection compared to those who do not have them.
A study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a significantly lower risk of reinfection compared to those who do not have them.